Innovation Pharmaceuticals Inc (IPIX)

[Chronic]

That's right frrol. The B-OM trial reported good but not great results in incidence of SOM, especially given what their interim results showed. However, those results were only reported for the "modified-intent-to-treat" and "per-protocol" groups. IPIX also released a chart showing delayed onset of SOM which looked great. However that was only for the "per-protocol" group (only 39 out of 61 patients!). The trial showed no improvement in Duration of SOM vs. placebo. Big negative. The company claims it didn't have enough data. Look at the duration numbers for Galera.